Orthopedic practice marketing: claims and stories

Orthopedic and sports medicine practices have a marketing advantage most specialties do not: patients search for them by a specific problem. Someone with a swollen knee after a weekend game, or a shoulder that has ached for months, types that problem into a search bar and wants to know who can see them soon. A practice that answers those searches clearly, with honest information about evaluation and options, is doing useful marketing.

The same specialty also has its own traps. Return-to-play promises, implant and device wording, regenerative injections, in-house imaging and physical therapy, and stories from local athletes each bring a specific federal rule into play. This guide walks through each one and ends with a review list you can use on your own website and ads. For the general rules on promoting in-house imaging, therapy and equipment to your own patients, see our guide to promoting in-office ancillary services. For shock wave devices and their approved indications, see our guide to shockwave therapy marketing. Hand and upper extremity practices have their own guide; see hand surgeon marketing. Spine centers that advertise laser surgery should read laser spine surgery advertising.

This is general information, not legal or medical advice. Sources cited were checked on October 29, 2026: the FTC Health Products Compliance Guidance (December 2022); the FTC Endorsement Guides, 16 CFR Part 255; the FTC rule on consumer reviews and testimonials, 16 CFR Part 465; 21 CFR 807.97; 21 CFR 1271.10; the FDA page Important Patient and Consumer Information About Regenerative Medicine Therapies (content current as of April 8, 2024); 42 U.S.C. 1395nn and 42 CFR 411.355(b); 42 U.S.C. 1320a-7b(b); 45 CFR 164.502(g) and 164.508(a)(3); and the Google Ads Healthcare and medicines and Unreliable claims policies. State law, including state medical board advertising rules, adds its own requirements, so ask counsel about your situation.

Market the condition and the access, not the outcome

The strongest pages on an orthopedic website are usually condition pages: knee pain, rotator cuff tears, ankle sprains, low back pain, stress fractures. Each one can explain what the problem is in plain words, how the practice evaluates it, the range of treatment options the practice offers, from conservative care to surgery where appropriate, and how quickly a new patient can be seen. That last point matters to an injured patient more than almost anything else, and it is something the practice can state accurately.

Where practices get into trouble is the outcome line. Phrases like “back on the field in six weeks”, “pain-free for good” or “avoid surgery” are claims about results. The FTC Health Products Compliance Guidance explains that health-related claims need competent and reliable scientific evidence, and that, as a general matter, this means randomized, controlled human clinical testing. Google Ads applies its own test: its Unreliable claims policy does not allow claims that entice the user with an improbable result as the likely outcome, even if that result is possible, and lists unproven claims of cures for medical ailments as an example.

Illustration: instead of “Get back to your sport in weeks, not months”, a sports medicine page could say “We see new sports injuries within two business days and explain your options, including a return-to-activity plan, at your first visit.” The second version describes what the practice does, and the practice can check whether it is true before publishing it.

Our guide to physician advertising rules covers the general framework, and the healthcare SEO page explains how we structure condition pages for search.

Implants, braces and devices: cleared is not approved

Orthopedic marketing often mentions devices: implants, bone stimulators, braces, shockwave units, imaging equipment. Many of these reach the market through FDA premarket notification, commonly called 510(k). 21 CFR 807.97 says that a determination of substantial equivalence under that process does not in any way denote official approval of the device, and that any representation creating an impression of official approval because of complying with premarket notification is misleading and constitutes misbranding.

In practice that means three things for your website and ads:

Do not write “FDA-approved” for a cleared device. If the manufacturer’s documentation says the device was cleared, say cleared, or simply describe the treatment without a regulatory label.
Stay inside the cleared or approved use. A device cleared for one purpose should not be marketed for another on your site.
Leave out brand names unless you have a reason to use them. A brand name adds little for a patient and can tie your page to the manufacturer’s own claims, which then become yours to substantiate.

Orthobiologics and regenerative injections

Many orthopedic and sports medicine practices are asked about injections described as regenerative, stem cell or orthobiologic treatments. This is the area where marketing language carries the most regulatory risk, and the FDA has been unusually direct about it.

The FDA page Important Patient and Consumer Information About Regenerative Medicine Therapies lists stem cells, stromal vascular fraction, umbilical cord blood, amniotic fluid, Wharton’s jelly, ortho-biologics and exosomes among unapproved products being marketed, and says these products require FDA licensure or approval to be marketed to consumers. The same page says regenerative medicine therapies have not been approved for the treatment of any orthopedic condition, and names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain. It adds that registration with FDA, or a listing on clinicaltrials.gov, does not mean a product is legally marketed.

The regulation that sorts which cell and tissue products need FDA approval, 21 CFR 1271.10, looks at factors such as whether a product is minimally manipulated and intended for homologous use only. Notably, it says homologous use is reflected by the labeling, advertising, or other indications of the manufacturer’s objective intent. Advertising is part of how intended use is judged, so the words used to market a product are not a side issue. Whether a particular product you use fits these criteria is a question for counsel and the manufacturer, not for your marketing team.

Google Ads adds its own limit. Its Healthcare and medicines policy does not allow the promotion of speculative or experimental medical treatments, or of cell or gene therapies, with an exception in the United States for FDA licensed or approved cell or gene therapies promoted by the entity that holds the license or approval. Google does allow ads for cell or gene therapies that are exclusively educational or informational.

A safe default for a website is to describe what a procedure involves, state its regulatory status accurately, avoid any claim that it treats or cures a condition unless you have the evidence and approval to say so, and avoid testimonials about results. Our guide to pain management clinic marketing covers similar ground for injection-based pain care.

In-house imaging, physical therapy and bracing

Many orthopedic groups offer X-ray, MRI, physical therapy and bracing under one roof, and “one-stop” convenience is a fair thing to tell patients about. Behind that message sits the federal physician self-referral law, often called the Stark law. 42 U.S.C. 1395nn generally prohibits a physician from referring Medicare patients for designated health services to an entity the physician has a financial relationship with, unless an exception applies. The list of designated health services in 1395nn(h)(6) includes physical therapy services; radiology services, including MRI, CT and ultrasound; durable medical equipment and supplies; and prosthetics, orthotics and prosthetic devices and supplies.

The exception most groups rely on for in-house services is the in-office ancillary services exception in 42 CFR 411.355(b). In summary, it sets conditions on who furnishes the service (the referring physician, a physician in the same group, or someone they supervise), where it is furnished (the same building, under detailed hours tests, or a centralized building the group uses) and how it is billed. Two parts touch marketing directly:

MRI, CT and PET notice. Under 411.355(b)(7), when a physician refers a patient for MRI, CT or PET under this exception, the patient must get written notice at the time of the referral that they may receive the same services elsewhere, with a list of at least five other suppliers within a 25-mile radius of the office, including their names, addresses and phone numbers. Your website should not suggest that patients must use your scanner.
Durable medical equipment is narrow. Under 411.355(b)(4), the durable medical equipment covered by this exception is limited to canes, crutches, walkers, folding manual wheelchairs and blood glucose monitors, with further conditions. If your site promotes other equipment dispensed in the office, confirm with counsel how that arrangement is structured before you advertise it.

These are compliance questions about how the services are set up, not about wording alone, so the marketing step is simple: describe what you offer accurately and make sure someone has confirmed the arrangement before it goes on the site. Our imaging center marketing guide covers the imaging notice in more detail, and the physical therapy marketing ideas guide covers the PT side.

Athlete stories, team relationships and endorsements

A local athlete who returns to play after treatment is a compelling story, and sports medicine practices are often asked to support school and club teams. Three sets of rules apply.

Disclosure of the relationship. The FTC Endorsement Guides say that when there is a connection between an endorser and the business that might materially affect the weight or credibility of the endorsement, and the audience would not expect it, the connection must be disclosed clearly and conspicuously (16 CFR 255.5(a)). Example 3 in that section describes a professional tennis player who talks about surgery at a named clinic without disclosing a paid relationship. The FTC says the endorsement is likely to be deceptive without a clear disclosure, that a disclosure in the closing credits is not enough, and that if the player posts about the surgery on social media, the relationship should be disclosed even if the only benefit was getting the surgery free or at a significantly reduced cost.

Typical results. Under 16 CFR 255.2(b), an endorsement that conveys a particular result implies that result is what people can generally expect, unless the ad clearly and conspicuously discloses the generally expected performance. An athlete’s fast return after surgery carries that implication. If you do not have evidence of what is typical for your patients, do not publish the result.

Patient privacy. If the athlete is your patient, a photo or story that ties them to treatment at your practice uses protected health information. 45 CFR 164.508(a)(3) requires a written HIPAA authorization for any use or disclosure of protected health information for marketing, with narrow exceptions for face-to-face communications and promotional gifts of nominal value. Many sports medicine patients are minors. Under 45 CFR 164.502(g)(3), a parent or guardian with authority to make health care decisions is generally treated as the minor’s personal representative, with exceptions, so the authorization usually comes from them. Get the signed form before the photo is posted, including posts by your staff on personal accounts. Our guide to patient testimonials and before-and-after photos includes a checklist for the authorization form.

Team sponsorships raise a separate question. If anything of value is given to a school, club or coach in a way that is tied to sending injured players to your practice, and any of those patients are covered by a federal health care program, the federal anti-kickback statute, 42 U.S.C. 1320a-7b(b), can come into play. Keep sponsorships separate from referrals, document what each side provides, and ask counsel before signing. Our guide to patient and physician referrals covers referral relationships in more detail.

A sports medicine program that works with schools and clubs has its own questions: team physician and athletic trainer agreements, free physicals days, concussion pages and youth sign-up forms. Those are covered in our sports medicine practice marketing guide.

Reviews from active patients

Sports patients are often happy to leave reviews, and recent reviews help local search. The FTC rule on consumer reviews and testimonials sets the limits. 16 CFR 465.2 prohibits fake or false consumer reviews and testimonials. 465.4 prohibits giving compensation or other incentives conditioned, expressly or by implication, on a review expressing a particular sentiment, positive or negative. 465.5 requires a clear disclosure when an officer or manager writes a review of their own business, and covers testimonials from employees and agents. Ask every patient the same way, without filtering for happy ones, and never offer a discount or gift tied to a good review. When you reply, do not confirm that the reviewer is a patient or discuss their care; our guide to replying to negative reviews under HIPAA covers how.

A review list for your website and ads

Illustration: a small orthopedic group with in-house X-ray, MRI and physical therapy wants to refresh its website before a new ad campaign. Its office manager could work through this list with the physicians and counsel.

Read every outcome line. Find phrases about return to sport, pain relief, avoiding surgery or recovery time. Keep only what you can support with evidence, and rewrite the rest to describe what you do.
Check every device and procedure name. Confirm the regulatory status from the manufacturer’s documentation, change any “FDA-approved” that should read cleared, and remove uses outside the cleared or approved indication.
Review regenerative and injection pages. Remove claims that a product treats or cures a condition unless you have the approval and evidence, and confirm the Google Ads campaign does not promote cell therapies.
Confirm in-house service arrangements. Ask counsel to confirm the imaging, PT and equipment arrangements fit an exception, and make sure the website does not say patients must use your services.
Collect signed authorizations. For every patient photo or story on the site and social accounts, find the signed HIPAA authorization, signed by a parent or guardian where the patient is a minor.
Add disclosures for athletes with a relationship. Anyone treated free, paid or otherwise connected to the practice who talks about it publicly needs a clear disclosure in the post itself.
Check the review process. Same request to every patient, no incentives tied to sentiment, no reviews written by staff without disclosure.

How we handle this

When we build or refresh an orthopedic or sports medicine website, we organize it around the conditions patients search for, write those pages to describe evaluation, options and access rather than results, and flag device, regenerative and in-house service claims for the practice and its counsel to confirm before launch. Our website work is built with HIPAA in mind, and we confirm in writing what a BAA covers before any patient information flows through a tool; if it is not covered, we do not route patient information through it. See our healthcare SEO and Google Ads for practices services for how we approach search and ads.

Can we say a procedure gets athletes back to their sport faster?

Only if you have competent and reliable scientific evidence for that claim, which the FTC Health Products Compliance Guidance says will, as a general matter, need to be randomized, controlled human clinical testing. Google Ads also does not allow improbable results presented as the likely outcome. Describing your process, such as how quickly you see new injuries, is usually safer and still useful.

Is it wrong to call a device FDA-approved?

It is wrong if the device was cleared through premarket notification rather than approved. 21 CFR 807.97 says a substantial equivalence determination does not denote official approval, and any representation creating that impression is misleading. Check the manufacturer’s documentation and use the correct term.

Can we run Google Ads for stem cell or other regenerative injections?

Google’s Healthcare and medicines policy does not allow ads promoting speculative or experimental treatments or cell or gene therapies, except in the United States for FDA licensed or approved cell or gene therapies promoted by the license or approval holder. Exclusively educational or informational ads about cell or gene therapies are allowed.

Do we need to tell patients they can get an MRI elsewhere?

If a physician refers a patient for MRI, CT or PET under the in-office ancillary services exception, 42 CFR 411.355(b)(7) requires written notice at the time of referral that the patient may get the service elsewhere, with a list of at least five other suppliers within 25 miles.

Can we post a photo of a high school athlete we treated?

Only with a signed HIPAA authorization for marketing under 45 CFR 164.508(a)(3). For a minor, the authorization generally comes from a parent or guardian acting as personal representative under 45 CFR 164.502(g)(3), subject to exceptions and state law.

If we treated a local athlete for free, do they have to mention it when they post?

Yes, if they are endorsing your practice. Example 3 in 16 CFR 255.5 says the relationship should be disclosed even when the only benefit was getting the procedure free or at a significantly reduced cost.

Orthopedic and sports medicine practice marketing: claims, referrals and athlete stories